The benefits of adherent patients are no secret: better outcomes, a more stable treatment pathway and of course better revenues for pharma are all possible.
When Emma Walmsley took the reins of GlaxoSmithKline (GSK) in 2016, becoming the first woman to head up a major pharmaceutical company, it was headline news.
Back in 2014, Pascal Soriot CEO of AstraZeneca managed to stave off a takeover bid from Pfizer with a bold promise to return the company to growth and achieve revenues of between $41 to $42 billion
In our first article we addressed the modern challenges to strategic planning; the growing complexity and uncertainty that presents challenges to creating a comprehensive and coherent vision of the
Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and antagonism that marked the early days of AIDS-related R&D and
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.